Physician profile
Jody Atzmon
NPI 1538530209
$1,547.46
in general payments reported to CMS, 2019-2025
11 companies · $15.68 in 2025
The $15.68 reported for 2025 was less than what a typical Pediatric Dentistry provider received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $296 · 2023: $725 · 2025: $15.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $586 · Food and Beverage: $129 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $586.47 |
| Food and Beverage | $129.11 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $586.47 | 2023 | Opalescence |
| A-Dec, INC. | $455.00 | 2019 | |
| Hu-Friedy Mfg. Co., LLC | $205.00 | 2020-2023 | |
| Henry Schein, INC. | $100.15 | 2023 | Convergent Dental, INC.-Laser,Solea,Model 3,Basic, Dentsply Sirona Imaging Units, Planmeca-Prox Single Stud 75in Arm |
| Septodont INC. | $72.93 | 2020 | |
| Pulpdent Corporation | $34.10 | 2019 | |
| Dentsply Sirona INC | $28.44 | 2019-2025 | Cavitron |
| B2d Marketing | $25.50 | 2020 | |
| Gc America INC. | $17.32 | 2020 | |
| Philips North America LLC | $13.28 | 2023 | |
| Biolase, INC. | $9.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Atzmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.